Douglas Lane & Associates, LLC Elanco Animal Health Inc Transaction History
Douglas Lane & Associates, LLC
- $6.9 Billion
- Q4 2024
A detailed history of Douglas Lane & Associates, LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 3,689,949 shares of ELAN stock, worth $41.5 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
3,689,949
Previous 3,767,784
2.07%
Holding current value
$41.5 Million
Previous $55.3 Million
19.21%
% of portfolio
0.65%
Previous 0.78%
Shares
22 transactions
Others Institutions Holding ELAN
# of Institutions
438Shares Held
448MCall Options Held
1.16MPut Options Held
1.12M-
Dodge & Cox San Francisco, CA83.2MShares$935 Million0.63% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$575 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$548 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$262 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.4MShares$230 Million11.79% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.33B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...